Upstream Bio (UPB)
Developing verekitug, a TSLP-receptor antibody for severe respiratory diseases.
$5.05
vs last close−0.45 (−8.11%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
estimated · in 42 days
EPS estimate
−$0.73
Revenue estimate
$522.5K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.41−$0.51−$0.74−$0.63−$0.79−$0.75−$0.73Pending
Estimate−$0.56−$0.49−$0.61−$0.78−$0.73−$0.75−$0.73−$0.73
Surprise+26.8%−4.1%−21.3%+19.2%−8.2%0.0%−0.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$613.0K$566.0K$937.0K$683.0K$668.0K$1.0M$773.0KPending
Estimate$384.8K$317.0K$317.0K$521.6K$584.0K$1.0M$561.4K$522.5K
Surprise+59.3%+78.5%+195.6%+31.0%+14.4%+0.6%+37.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.72 | — | — |
| Sep 2028 | −$0.71 | — | — |
| Jun 2028 | −$0.68 | — | — |
| Mar 2028 | −$0.67 | — | — |
| Dec 2027 | −$0.67 | — | — |
| Sep 2027 | −$0.66 | — | — |
| Jun 2027 | −$0.75 | — | — |
| Mar 2027 | −$0.76 | — | — |
| Dec 2026 | −$0.73 | — | — |
| Nov 2026 | −$0.73 | — | — |
| Aug 2026 | −$0.73 | −$0.73 | −0.6% |
| May 2026 | −$0.75 | −$0.75 | 0.0% |
| Mar 2026 | −$0.73 | −$0.79 | −8.2% |
| Nov 2025 | −$0.78 | −$0.63 | +19.2% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Oct 2024 | — | — | — |
| Dec 2023 | |||
| Sep 2023 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.72 | — | — | $976.4K | — | — | — |
| Sep 2028 | −$0.71 | — | — | $966.7K | — | — | — |
| Jun 2028 | −$0.68 | — | — | $920.7K | — | — | — |
| Mar 2028 | −$0.67 | — | — | $911.5K | — | — | — |
| Dec 2027 | −$0.67 | — | — | $414.3K | — | — | — |
| Sep 2027 | −$0.66 | — | — | $410.2K | — | — | — |
| Jun 2027 | −$0.75 | — | — | $406.2K | — | — | — |
| Mar 2027 | −$0.76 | — | — | $402.2K | — | — | — |
| Dec 2026 | −$0.73 | — | — | $524.1K | — | — | — |
| Nov 4, 2026 | −$0.73 | — | — | $522.5K | — | — | — |
| Aug 11, 2026 | −$0.73 | −$0.73 | −0.6% | $561.4K | $773.0K | +37.7% | −4.7% |
| May 13, 2026 | −$0.75 | −$0.75 | 0.0% | $1.0M | $1.0M | +0.6% | +4.6% |
| Mar 26, 2026 | −$0.73 | −$0.79 | −8.2% | $584.0K | $668.0K | +14.4% | +3.4% |
| Nov 5, 2025 | −$0.78 | −$0.63 | +19.2% | $521.6K | $683.0K | +31.0% | −4.3% |
| Aug 6, 2025 | |||||||
| May 6, 2025 | |||||||
| Mar 12, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Oct 11, 2024 | — | — | — | — | — | — | — |
| Dec 31, 2023 | |||||||
| Sep 30, 2023 |